Maravai LifeSciences Sustainability Profile
Maravai LifeSciences, a leading provider in the life sciences sector, is headquartered in the United States and operates across key regions globally. Founded in 2016, the company has rapidly established itself as a pivotal player in the biotechnology industry, focusing on critical areas such as nucleic acid production, protein detection, and cell culture solutions. Maravai's core offerings include high-quality reagents and services that support the development of therapeutics and diagnostics. Their unique approach to custom synthesis and scalable production sets them apart in a competitive market. With a commitment to innovation, Maravai has achieved significant milestones, including strategic acquisitions that enhance their capabilities and market reach. Recognised for their excellence, Maravai LifeSciences continues to drive advancements in life sciences, contributing to the global health landscape.
DitchCarbon Score
How does Maravai LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maravai LifeSciences's score of 33 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Maravai LifeSciences's reported carbon emissions
In 2024, Maravai LifeSciences reported total carbon emissions of approximately 12,000,000 kg CO2e, comprising 862,580 kg CO2e from Scope 1, 2,208,570 kg CO2e from Scope 2 (market-based), and a significant 9,631,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions included 56,213,130 kg CO2e from purchased goods and services, 10,027,390 kg CO2e from capital goods, and 3,943,670 kg CO2e from business travel. In 2023, the company’s emissions were slightly lower, with total emissions of about 10,000,000 kg CO2e, including 736,590 kg CO2e from Scope 1 and 1,993,000 kg CO2e from Scope 2 (market-based). The Scope 3 emissions for that year were also substantial, with 10,572,000 kg CO2e from capital goods and 8,002,000 kg CO2e from purchased goods and services. Maravai LifeSciences has committed to achieving net-zero emissions, demonstrating its dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company is currently classified as "Committed" to near-term targets, although specific reduction targets have not been disclosed. The emissions data is sourced directly from Maravai LifeSciences Holdings, Inc., with no cascaded data from a parent organization. The company continues to focus on reducing its carbon footprint while maintaining transparency in its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 330,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,103,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
How Carbon Intensive is Maravai LifeSciences's Industry?
How Carbon Intensive is Maravai LifeSciences's Location?
Maravai LifeSciences's Scope 3 Categories Breakdown
Maravai LifeSciences's Scope 3 emissions, which increased by 232% last year and increased by approximately 232% since 2023, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 77% of Scope 3 emissions.
Top Scope 3 Categories
Maravai LifeSciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Maravai LifeSciences has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Telesis Bio, Inc.
Thermo Fisher Scientific
Frequently Asked Questions
Common questions about Maravai LifeSciences's sustainability data and climate commitments